The US Food and Drug Administration (FDA) has issued safety guidelines to suppliers using peanut products in a bid to reduce the presence of salmonella in foods.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Within the guidelines, the FDA recommends measures that manufacturers can take to address the risk for peanut-derived products received from ingredient suppliers and for the products they themselves produce.
The guidance also advises that manufacturers obtain their peanut-derived ingredients only from suppliers who use production processes that have been demonstrated to “adequately reduce the presence of salmonella”, or that they ensure that their own demonstrate the same.
The guidance and bulletin are being issued in the midst of the ongoing, multi-state outbreak of consumer illness associated with consumption of food products containing peanut-derived ingredients produced by peanut processor Peanut Corporation of America.
The latest reported illness, on 13 February, carried the case count to 683 in 46 states, according to figures released yesterday (10 March) by the Centers for Disease Control and Prevention. The outbreak has been linked to nine deaths.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
